Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Biotechnology Advances
|
April 10, 2022
Microbial carbohydrate-binding toxins - From etiology to biotechnological application
Natalia Danielewicz, Francesca Rosato, Wenyue Dai, et al.
New Biotechnology
|
May 31, 2023
Genetic code expansion in E. coli enables production of a functional 'ready-to-click' T cell receptor-specific scFv
Rajeev Pasupuleti, Francesca Rosato, Dajana Kolanovic, et al.
ACS Omega
|
May 8, 2023
Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy
Natalia Danielewicz, Francesca Rosato, Jana Tomisch, et al.
Toxins
|
November 25, 2021
The Two Sweet Sides of Janus Lectin Drive Crosslinking of Liposomes to Cancer Cells and Material Uptake
Lina Siukstaite, Francesca Rosato, Anna Mitrovic, et al.
Toxins
|
June 23, 2022
In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in <i>Escherichia coli</i>
Natalia Danielewicz, Wenyue Dai, Francesca Rosato, et al.
Computational and Structural Biotechnology Journal
|
November 24, 2022
Extending Janus lectins architecture: Characterization and application to protocells
Simona Notova, Lina Siukstaite, Francesca Rosato, et al.
Journal of Translational Medicine
|
December 9, 2022
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, et al.
European Journal of Medicinal Chemistry
|
August 28, 2021
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27
Thanigaimalai Pillaiyar, Francesca Rosato, Monika Wozniak, et al.
RSC Chemical Biology
|
December 3, 2025
A novel SadP-scFv UCHT1 lectibody activates T cells and mediates lysis of Burkitt's lymphoma cells
Jana Tomisch, Jonas Gräber, Olga N Makshakova, et al.
Clinical Endocrinology
|
February 21, 2006
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial
Annamaria Colao, Rosario Pivonello, Francesca Rosato, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Biotechnology Advances
|
April 10, 2022
Microbial carbohydrate-binding toxins - From etiology to biotechnological application
Natalia Danielewicz, Francesca Rosato, Wenyue Dai, et al.
New Biotechnology
|
May 31, 2023
Genetic code expansion in E. coli enables production of a functional 'ready-to-click' T cell receptor-specific scFv
Rajeev Pasupuleti, Francesca Rosato, Dajana Kolanovic, et al.
ACS Omega
|
May 8, 2023
Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy
Natalia Danielewicz, Francesca Rosato, Jana Tomisch, et al.
Toxins
|
November 25, 2021
The Two Sweet Sides of Janus Lectin Drive Crosslinking of Liposomes to Cancer Cells and Material Uptake
Lina Siukstaite, Francesca Rosato, Anna Mitrovic, et al.
Toxins
|
June 23, 2022
In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in <i>Escherichia coli</i>
Natalia Danielewicz, Wenyue Dai, Francesca Rosato, et al.
Computational and Structural Biotechnology Journal
|
November 24, 2022
Extending Janus lectins architecture: Characterization and application to protocells
Simona Notova, Lina Siukstaite, Francesca Rosato, et al.
Journal of Translational Medicine
|
December 9, 2022
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, et al.
European Journal of Medicinal Chemistry
|
August 28, 2021
Structure-activity relationships of agonists for the orphan G protein-coupled receptor GPR27
Thanigaimalai Pillaiyar, Francesca Rosato, Monika Wozniak, et al.
RSC Chemical Biology
|
December 3, 2025
A novel SadP-scFv UCHT1 lectibody activates T cells and mediates lysis of Burkitt's lymphoma cells
Jana Tomisch, Jonas Gräber, Olga N Makshakova, et al.
Clinical Endocrinology
|
February 21, 2006
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial
Annamaria Colao, Rosario Pivonello, Francesca Rosato, et al.
Page
of 2